PARIS October 11th, 2023 – BG IRIS, Bryan Garnier’s research platform, is pleased to release the “Rising Stars: Beyond the hype”, a comprehensive analysis of the space sector and underlying M&A market activities.
NewSpace is not just a buzzword; it’s a transformative force redefining the space industry. In this ever-evolving landscape, private capital is surging, innovation cycles are shrinking, and commercial applications are multiplying. To help investors stay ahead of the curve, we present our analysis of the NewSpace potential and underlying market activities.
Within this comprehensive white paper, we guide investors through the NewSpace landscape, unveil the prevailing trends, and assess the genuine opportunities that lie beyond the hype. Our analysis uncovers challenges and expert opinions that will shape the industry’s future.
We find that while the tech sector’s investment pace has moderated, NewSpace remains resilient. Although capital is becoming scarcer, this shift is leading to more solid grounds for investing. Governmental support remains pivotal, fueled by concerns over sovereignty. The potential for commercial applications remains promising.
To dive deep into this topic and discover how NewSpace is poised to shape the future of the space industry, request the white paper.
Thomas Coudry
BG IRIS
About Bryan, Garnier & Co
Bryan, Garnier & Co is a European growth investment bank that helps healthcare and technology companies become global champions. By combining extensive sector expertise with an entrepreneurial mindset, Bryan Garnier provides companies and their investors with independent growth strategic advice, and privileged access to buyers and capital in Europe, the US and Asia.
As a full-service investment bank, the firm offering includes private and public growth financing solutions, mergers and acquisitions (M&A) advisory, research insights, and institutional sales & execution. Founded in 1996, Bryan Garnier & Co is an independent partnership with around 200 employees located in major financial centres in Europe and the US.